Make your one-time, tribute, or recurring online gift to support brain tumour patient programs and research today:

620 Colborne St., Suite 301
London, Ontario, Canada N6B 3R9
Fax: 519-642-7192
The office is open Monday - Friday, 8:30 am - 4:30 pm (EST)
Request an Information Kit or copies of our resources here.
| Find us on Facebook | ||
| Follow us on Twitter |
New research about the brain tumour treatment Bevacizumab (Avastin®) was released at the recent American Society of Clinical Oncology (ASCO) 2013 Annual Meeting. Results were presented from two recent clinical trials focused on the treatment. Because Avastin is one of the few new treatments that have been offered to brain tumour patients in recent years, Brain Tumour Foundation of Canada was eagerly awaiting these results.
Learn moreWhen Carol Kovosi talks about......
Learn moreIn 2011 Micah Nepon’s brother Jonah was diagnosed......
Learn more